Tag: ABBVs

Could AbbVie Inc. (ABBV)’s Post-Humira Transformation Drive the Next Phase of Growth?

AbbVie Inc. (NYSE:ABBV) recently released its first-quarter 2026 financial results, showcasing a robust performance with worldwide net revenues

AbbVie Inc. (ABBV)’s Pipeline Advances with Temab-A and ABBV-706, Shares Flat

AbbVie Inc. (NYSE:ABBV) made significant strides in its oncology pipeline at the ASCO 2025 Annual Meeting, unveiling promising